Corda Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.4M Buy
1,188,027
+59,130
+5% +$1.57M 2.31% 22
2025
Q4
$28.1M Sell
1,128,897
-36,357
-3% -$917K 2.04% 22
2025
Q3
$29.7M Buy
1,165,254
+21,740
+2% +$537K 2.09% 22
2025
Q2
$27.7M Buy
1,143,514
+68,451
+6% +$1.6M 2.04% 24
2025
Q1
$27.2M Buy
1,075,063
+59,047
+6% +$1.55M 2.17% 24
2024
Q4
$27M Buy
1,016,016
+5,162
+0.5% +$140K 2.15% 23
2024
Q3
$29.3M Buy
1,010,854
+40,063
+4% +$1.17M 2.28% 21
2024
Q2
$27.2M Buy
970,791
+58,954
+6% +$1.62M 2.21% 21
2024
Q1
$25.3M Buy
911,837
+129,776
+17% +$3.6M 2.01% 24
2023
Q4
$22.5M Buy
782,061
+16,069
+2% +$486K 1.89% 26
2023
Q3
$25.4M Buy
765,992
+75,024
+11% +$2.65M 2.3% 21
2023
Q2
$25.3M Buy
690,968
+11,354
+2% +$442K 1.98% 22
2023
Q1
$27.7M Buy
679,614
+13
+0% +$561 2.22% 17
2022
Q4
$34.8M Sell
679,601
-2,813
-0.4% -$135K 2.84% 12
2022
Q3
$29.9M Buy
682,414
+9,946
+1% +$483K 2.68% 14
2022
Q2
$35.3M Buy
672,468
+3,992
+0.6% +$203K 2.99% 12
2022
Q1
$34.6M Sell
668,476
-10,890
-2% -$565K 2.68% 11
2021
Q4
$40.1M Sell
679,366
-504
-0.1% -$25K 3.15% 8
2021
Q3
$29.2M Buy
679,870
+2,412
+0.4% +$107K 2.54% 17
2021
Q2
$26.5M Buy
677,458
+12,544
+2% +$488K 2.28% 18
2021
Q1
$24.1M Buy
664,914
+11,125
+2% +$395K 2.18% 21
2020
Q4
$24.1M Sell
653,789
-29,467
-4% -$1.08M 2.42% 18
2020
Q3
$23.8M Buy
683,256
+3,156
+0.5% +$111K 2.59% 15
2020
Q2
$21.1M Buy
680,100
+34,126
+5% +$1.16M 2.43% 22
2020
Q1
$20M Sell
645,974
-7,804
-1% -$266K 2.5% 18
2019
Q4
$24.3M Sell
653,778
-12,289
-2% -$438K 2.61% 12
2019
Q3
$22.7M Buy
666,067
+1,246
+0.2% +$45.3K 2.49% 15
2019
Q2
$27.3M Sell
664,821
-19,139
-3% -$760K 2.96% 9
2019
Q1
$27.6M Sell
683,960
-11,157
-2% -$447K 3.19% 7
2018
Q4
$28.8M Sell
695,117
-16,634
-2% -$691K 3.54% 5
2018
Q3
$29.8M Sell
711,751
-14,220
-2% -$547K 3.53% 5
2018
Q2
$25M Sell
725,971
-3,099
-0.4% -$106K 3.09% 9
2018
Q1
$24.5M Buy
729,070
+72,995
+11% +$2.51M 3.07% 12
2017
Q4
$22.5M Sell
656,075
-15,276
-2% -$521K 2.7% 13
2017
Q3
$22.7M Buy
671,351
+32,417
+5% +$1.04M 2.94% 11
2017
Q2
$20.4M Buy
638,934
+27,339
+4% +$862K 2.9% 9
2017
Q1
$19.9M Buy
611,595
+37,170
+6% +$1.17M 2.97% 9
2016
Q4
$17.7M Buy
574,425
+18,344
+3% +$560K 2.74% 13
2016
Q3
$17.6M Buy
556,081
+18,268
+3% +$611K 2.87% 11
2016
Q2
$18M Buy
537,813
+8,654
+2% +$276K 2.87% 12
2016
Q1
$14.9M Buy
529,159
+283,653
+116% +$8.1M 2.61% 17
2015
Q4
$7.52M Buy
245,506
+1,900
+0.8% +$59.8K 1.41% 30
2015
Q3
$7.26M Sell
243,606
-8,031
-3% -$258K 1.41% 30
2015
Q2
$8.01M Sell
251,637
-13,612
-5% -$444K 1.49% 28
2015
Q1
$8.76M Sell
265,249
-4,778
-2% -$152K 1.62% 25
2014
Q4
$7.98M Buy
270,027
+4,849
+2% +$139K 1.51% 27
2014
Q3
$7.44M Sell
265,178
-272
-0.1% -$7.63K 1.54% 27
2014
Q2
$7.47M Buy
265,450
+797
+0.3% +$22.7K 1.56% 28
2014
Q1
$8.06M Buy
264,653
+1,831
+0.7% +$54.6K 1.98% 23
2013
Q4
$7.64M Sell
262,822
-6,388
-2% -$186K 1.84% 24
2013
Q3
$7.34M Sell
269,210
-5,158
-2% -$140K 2% 22
2013
Q2
$7.29M Buy
+274,368
New +$7.58M 2.48% 19

Other funds holding PFE

Corda Investment Management's PFE Position: Q1 2026 in Review

Corda Investment Management increased its Pfizer (PFE) stake by 5.2% in Q1 2026, buying an estimated $1.57M and bringing the position to 1,188,027 shares worth $33.4M. The position accounts for 2.31% of the portfolio, ranked #22.

Corda Investment Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $40.1M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Corda Investment Management held 1,188,027 shares of Pfizer worth $33.4M as of Q1 2026.
  • Corda Investment Management bought 59,130 Pfizer shares in Q1 2026, an estimated $1.57M.
  • Pfizer made up 2.31% of Corda Investment Management's portfolio in Q1 2026, its #22 holding.
  • Corda Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Corda Investment Management's Pfizer position peaked at $40.1M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Corda Investment Management's 13F filing for Q1 2026, filed 4 May 2026.